PharmaCyte Biotech (PMCB) Enterprise Value Growth (1y) (2013 - 2026)
PharmaCyte Biotech (PMCB) Enterprise Value Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -21.36% |
| Jan 31, 2026 | -22.57% |
| Oct 31, 2025 | 25.11% |
| Jul 31, 2025 | 58.82% |
| Apr 30, 2025 | 69.03% |
| Jan 31, 2025 | 72.63% |
| Oct 31, 2024 | 71.62% |
| Jul 31, 2024 | 56.29% |
| Apr 30, 2024 | 26.25% |
| Jan 31, 2024 | 15.73% |
| Oct 31, 2023 | 4.60% |
| Jul 31, 2023 | 9.20% |
| Apr 30, 2023 | 20.33% |
| Jan 31, 2023 | 16.16% |
| Oct 31, 2022 | 11.47% |
| Jul 31, 2022 | -8,471.89% |
| Apr 30, 2022 | -3,778.14% |
| Jan 31, 2022 | -2,702.99% |
| Oct 31, 2021 | -2,238.69% |
| Jul 31, 2021 | 55.72% |